Trial Site Detail

 

Drug:
PLX3397 (PLX108-01)
Trial:
Safety Study of PLX108-01 in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Comprehensive Cancer Centers of Nevada

3730 S. Eastern Avenue     
Las Vegas , NV 89169
USA

 

Principal Investigator:
Fadi Braiteh, MD, CPI
Contact:
Muhammad Khan, MD 281-863-6538 muhammad.khan@mckesson.com
Activation Status of this Site:
Closed
Notes about this Site:
Comprehensive Cancer Centers of Nevada Website:
http://www.cccnevada.com/clinical-research/active-trials/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.